Seroconversion for cytomegalovirus infection in a cohort of pregnant women in Québec, 2010-2013

Epidemiology and Infection

Volumn 144, Issue 8, 2016, Pages 1701-1709

  Lamarre, V ^a   Gilbert, N L ^b,c   Rousseau, C ^a,c   Gyorkos, T W ^d,e   Fraser, W D ^f  

^a UNIVERSITY OF MONTREAL   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

Cytomegalovirus; infectious disease epidemiology; pregnancy; prevention; serology

Indexed keywords

IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CANADA; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PERCEPTION DEAFNESS; PREGNANT WOMAN; QUESTIONNAIRE; SEROCONVERSION; SEROPREVALENCE; THIRD TRIMESTER PREGNANCY; UNITED STATES; BLOOD; CYTOMEGALOVIRUS INFECTIONS; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDY; QUEBEC; SEROEPIDEMIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOGLOBULIN G; INCIDENCE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; QUEBEC; SEROCONVERSION; SEROEPIDEMIOLOGIC STUDIES; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84951290354     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268815003167     Document Type: Article

References (31)

1. Kenneson A, Cannon MJ. Review and meta-Analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Reviews in Medical Virology 2007; 17: 253-276
2. Larke RP, et al. Congenital cytomegalovirus infection in an urban Canadian community. Journal of Infectious Diseases 1980; 142: 647-653
3. Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Reviews inMedical Virology 2007; 17: 355-363
4. Britt W. Cytomegalovirus. In: Remington JS, et al. eds. Infectious Diseases of the Fetus and Newborn, 8th edn. Philadelphia, PA, USA: Elsevier, 2015, pp. 724-781
5. Stagno S, et al. Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. Journal of the American Medical Association 1986; 256: 1904-1908
6. Picone O, et al. A series of 238 cytomegalovirus primary infections during pregnancy: description and outcome. Prenatal Diagnosis 2013; 33: 751-758
7. Fowler KB, et al. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. New England Journal of Medicine 1992; 326: 663-667
8. Adler SP. Cytomegalovirus and child day care. Evidence for an increased infection rate among day-care workers. New England Journal of Medicine 1989; 321: 1290-1296
9. Sohn YM, et al. Cytomegalovirus infection in sexually active adolescents. Journal of Infectious Diseases 1991; 163: 460-463
10. Marshall BC, Adler SP. The frequency of pregnancy and exposure to cytomegalovirus infections among women with a young child in day care. American Journal of Obstetrics and Gynecology 2009; 200: 163
11. Pass RF, et al. Increased rate of cytomegalovirus infection among day care center workers. Pediatric Infectious Disease Journal 1990; 9: 465-470
12. Ford-Jones EL, et al. Cytomegalovirus infections in Toronto child-care centers: a prospective study of viral excretion in children and seroconversion among daycare providers. Pediatric Infectious Disease Journal 1996; 15: 507-514
13. Joseph SA, et al. Risk factors for cytomegalovirus seropositivity in a population of day care educators in Montréal, Canada. Occupational Medicine 2005; 55: 564-567
14. Dollard SC, et al. National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity. Clinical and Vaccine Immunology 2011; 18: 1895-1899
15. Fraser W, et al. 3-D Study: The Integrated Research Network in Perinatology of Quebec and Eastern Ontario (IRNPQEO). Canadian National Perinatal Research Meeting Banff, Canada, 2014
16. Ulm K. A simple method to calculate the confidence interval of a standardized mortality ratio (SMR). American Journal of Epidemiology 1990; 131: 373-375
17. Dowd JB, Aiello AE, Alley DE. Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III. Epidemiology and Infection 2009; 137: 58-65
18. Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Reviews in Medical Virology 2010; 20: 202-213
19. Plante R, Malenfant R. Reproductive health and work: different experiences. Journal of Occupational and Environmental Medicine 1998; 40: 964-968
20. Hyde TB, Schmid DS, Cannon MJ. Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Reviews in Medical Virology 2010; 20: 311-326
21. Duchesne L. The demographic situation in Québec-Report 1999. Québec's Institute of Statistics, 2000
22. Girard C. Births and fecundity. In: Girard C, et al. eds. Québec's Demographical Report, 2014 edition. Québec, Canada: Québec's Institute of Statistics, 2014, pp. 41-58
23. Rose R. Women and the workplace in Québec: statistical portrait. Montréal, Québec, Canada: Consultative committee Women in workforce development, 2013
24. Giguère C, Desrosiers H. Care settings from birth to 8 years of age: use andeffect on thedevelopment of children, volume 5 part1. In: Longitudinal Study of the Development ofQuébec'sChildren (ELDEQ1998-2010)-from Birth to 8 Years of Age. Québec, Canada: Québec's Institute of Statistics, 2010
25. Wizman S, et al. Risk factors for cytomegalovirus susceptibility among pregnant women an epidemiological and socio-demographic study. IDWeek 2013. San Francisco, CA, USA, 2013; Abstract 1782
26. Price SM, et al. Educating women about congenital cytomegalovirus: assessment of health education materials through a web-based survey. BMC Women's Health 2014; 14: 144
27. American College of Obstetricians and Gynecologists. Practice bulletin no. 151: Cytomegalovirus, parvovirus B19, varicella zoster, and toxoplasmosis in pregnancy. Obstetrics and Gynecology 2015; 125: 1510-1525
28. Society of Obstetricians and Gynaecologists of Canada. Cytomegalovirus infection in pregnancy. Journal of Obstetrics and Gynaecology Canada 2010; 32: 248-354
29. Adler SP, et al. Prevention of child-To-mother transmission of cytomegalovirus by changing behaviors: a randomized controlled trial. Pediatric Infectious Disease Journal 1996; 15: 240-246
30. Adler SP, et al. Prevention of child-To-mother transmission of cytomegalovirus among pregnant women. Journal of Pediatrics 2004; 145: 485-491
31. Public Health Agency of Canada. What Mothers Say: the Canadian Maternity Experiences Survey. Ottawa, Canada, 2009, 225 pp.